(商品説明)
乳牛の卵巣起源の不妊症の治療と妊娠率の改善に効果を発揮する注射用レセプタクル0.004 mg / ml溶液。
溶液1 mlに含まれるもの:活性物質:ブセレリンアセテート0.0042mg(ブセレリン0.004mgに相当)。賦形剤:ベンジルアルコール20 mg。
対象種:牛、馬、ウサギ、豚(金)、マス。
乳牛の発情期と同時期、および10日間の定時授精レジメンの一部として、黄体溶解活性を持つPGF 2aアナログと組み合わせて使用した場合、これらの牛の受胎間隔までの分娩が減少し、成熟した卵胞の排卵を誘発させます。
固定時間人工授精プログラムを促進するために、発情期と同時期に使用すれば発情期後にブタ(雌ブタ)の排卵を誘発します。
また、ウサギの受胎率の改善と排卵の誘発のためや、ニジマスの卵の結合による剥ぎ取りを促進し、死亡率を減らすために使用します。
この製品は、妊娠率の改善、排卵の誘発などに使用することを目的としているため、妊娠中ではなく、交配または授精の前に使用する必要があります。
(使用方法)
適切な時期に適切な量を、筋肉内、静脈内、皮下に注射します。
投与時期、投与量は必ず獣医師に指示の本、投与して下さい。
(使用期限)
ご注文時より最低1年以上のもの
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Veterelin 20 ML
Veterelin 20 ML
Reproductive System, recommended for cattle, rabbits, horses and pigs
More information:
VETERELIN 0.004 mg / ml solution for injection for cattle, horses, pigs and rabbits
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each ml of the solution for injection contains:
Active substance:
Buserelin .................. ............................................... 0.004 mg
( equivalent to 0.0042 mg of buserelin acetate)
Excipients:
Benzyl alcohol (E 1519) ................................. ............ 10 mg
PHARMACEUTICAL FORM:
Solution for injection.
Clear clear solution.
CLINICAL DATA: Target
species:
Cattle, horses, pigs and rabbits
Indications for use, specifying the target species:
Cows:
- Induction of ovulation or delayed ovulation
- Treatment of the anestrus
- Treatment of follicular cysts with or without signs of nymphomania.
- Increase in the fertility rate in artificial insemination, after synchronization
of estrus with a PGF2 analog. Results may depend on
breeding conditions .
Mares:
- Induction to ovulation and consequently synchronization of ovulation just before mating.
- Treatment of follicular cysts - with or without signs of nymphomania.
Rabbits for reproduction:
- Improvement of the fertility index and induction of ovulation in postpartum insemination.
Gilt sows (gilts):
Induction of ovulation after synchronization of heat with a progesterone analog (altrenogest) to perform artificial insemination.
Contraindications:
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Special warnings for each target species
Treatment with a GnRH analog is only symptomatic and does not eliminate the
underlying causes of the fertility disorder.
Special precautions for use:
Special precautions for use in animals:
Gilt sows (gilts):
The use of the veterinary medicine used contrary to the recommended protocols can result in the formation of follicular cysts that can negatively affect fertility
and prolificacy. Using aseptic technique is recommended.
Specific precautions to be taken by the person administering the medicine to animals:
Avoid contact with the skin and eyes. In case of accidental contact, wash
with plenty of water. In case the skin comes into contact with the veterinary medicinal product, wash the
exposed area immediately with soap and water, as GnRH analogs are absorbed through the skin.
Pregnant women should not administer the veterinary medicinal product because it is
has observed in laboratory animals that buserelin is foetotoxic.
Given the potential effects on reproductive function, women of childbearing potential should handle the veterinary medicinal product with caution.
When administering the veterinary medicinal product, measures shall be taken to prevent accidental self-injection by properly restraining the animals and keeping the
application needle protected until the moment of injection.
In case of accidental self-injection, consult a doctor and show the package insert.
Wash your hands after use.
Adverse reactions (frequency and seriousness):
None known.
Use during pregnancy, lactation or lay:
Its use is not recommended during pregnancy and lactation.
Interaction with other drugs and other forms of interaction:
None known.
Dosage and route of administration:
In cattle, horses and rabbits, the intramuscular (IM) route is preferable. The intravenous (iv) or subcutaneous
(s c.) Route can also be used .
In pigs, it is preferable to use the intramuscular (IM) route. The intravenous (iv) route can also be used.
Overdose (symptoms, emergency measures, antidotes), if necessary:
In the case of repeated administrations of a dose corresponding to 3.5 ml of veterinary drug, a decrease in feed consumption may be observed in sows
gilts after the second injection. This effect is temporary and no
specific treatment is required .
Withdrawal time (s):
Meat: zero days
Milk: zero hours
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Gonadotropin-releasing hormones.
ATCvet code: QH01CA90
PHARMACEUTICAL PARTICULARS
List of excipients:
Benzyl alcohol (E 1519)
Sodium chloride Sodium
dihydrogen phosphate monohydrate
Sodium hydroxide
Water for injections
Incompatibilities:
In the absence of compatibility studies, this veterinary medicinal product must not be mixed
with other medicinal products.
Shelf life:
Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Shelf life after first opening the immediate packaging: 8 hours
Special precautions for storage:
Do not store above 25oC.
Store in the outer carton in order to protect from light.
Nature and composition of immediate packaging:
Transparent glass vials of 10 (or 20) ml capacity, fitted with a
bromobutyl rubber stopper and an aluminum cap, with a blue polypropylene Flip-Off seal.
Box containing:
1 vial of 10 ml
1 vial of 20 ml
5 vials of 10 ml
Not all formats may be marketed.
Special precautions for the disposal of unused veterinary medicine or,
where appropriate, the residues derived from its use:
All unused veterinary medicine or the residues derived from it must be disposed of in accordance with local regulations.
MARKETING AUTHORIZATION HOLDER
LABORATORIOS CALIER, SA
C / Barcelonès, 26 (Pla del Ramassà)
LES FRANQUESES DEL VALLÈS, (Barcelona)
MARKETING AUTHORIZATION NUMBER (S)
2317 SP
DATE OF FIRST AUTHORIZATION OR RENEWAL THE AUTHORIZATION
Date of the first authorization: June 15, 2011
Authorization renewal date: July 14, 2016
DATE OF THE REVISION OF THE TEXT
February 15, 2018
PROHIBITION OF SALE, SUPPLY AND / OR USE
Dispensing conditions: Medication subject to veterinary prescription.
Administration conditions: Exclusive administration by the veterinarian (in the case of
intravenous administration) or under his supervision and control.
Laboratory:
Calier
ベテレリン(ブセレリン0.004mg/ml)20ml注射液/Veterelin 20 ML
- 品番: 52
- 在庫: 在庫あり
-
¥12,900